Literature DB >> 30387875

Risk factors for endometrial cancer: An umbrella review of the literature.

Olivia Raglan1,2, Ilkka Kalliala1,3, Georgios Markozannes4, Sofia Cividini5, Marc J Gunter6, Jaya Nautiyal1, Hani Gabra1,7, Evangelos Paraskevaidis8, Pierre Martin-Hirsch9,10, Kostas K Tsilidis4,11, Maria Kyrgiou1,2.   

Abstract

Although many risk factors could have causal association with endometrial cancer, they are also prone to residual confounding or other biases which could lead to over- or underestimation. This umbrella review evaluates the strength and validity of evidence pertaining risk factors for endometrial cancer. Systematic reviews or meta-analyses of observational studies evaluating the association between non-genetic risk factors and risk of developing or dying from endometrial cancer were identified from inception to April 2018 using PubMed, the Cochrane database and manual reference screening. Evidence was graded strong, highly suggestive, suggestive or weak based on statistical significance of random-effects summary estimate, largest study included, number of cases, between-study heterogeneity, 95% prediction intervals, small study effects, excess significance bias and sensitivity analysis with credibility ceilings. We identified 171 meta-analyses investigating associations between 53 risk factors and endometrial cancer incidence and mortality. Risk factors were categorised: anthropometric indices, dietary intake, physical activity, medical conditions, hormonal therapy use, biochemical markers, gynaecological history and smoking. Of 127 meta-analyses including cohort studies, three associations were graded with strong evidence. Body mass index and waist-to-hip ratio were associated with increased cancer risk in premenopausal women (RR per 5 kg/m2 1.49; CI 1.39-1.61) and for total endometrial cancer (RR per 0.1unit 1.21; CI 1.13-1.29), respectively. Parity reduced risk of disease (RR 0.66, CI 0.60-0.74). Of many proposed risk factors, only three had strong association without hints of bias. Identification of genuine risk factors associated with endometrial cancer may assist in developing targeted prevention strategies for women at high risk.
© 2018 UICC.

Entities:  

Keywords:  endometrial cancer; gynaecological oncology; obesity; risk factors; umbrella review; uterine cancer

Mesh:

Year:  2019        PMID: 30387875     DOI: 10.1002/ijc.31961

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  84 in total

1.  Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer.

Authors:  Robert Hoffmann; Sayantani Sarkar Bhattacharya; Debarshi Roy; Boris Winterhoff; Ralf Schmidmaier; Keith Dredge; Edward Hammond; Viji Shridhar
Journal:  Biochem Pharmacol       Date:  2020-04-28       Impact factor: 5.858

2.  Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review.

Authors:  Elena Dragioti; Marco Solmi; Angela Favaro; Paolo Fusar-Poli; Paola Dazzan; Trevor Thompson; Brendon Stubbs; Joseph Firth; Michele Fornaro; Dimitrios Tsartsalis; Andre F Carvalho; Eduard Vieta; Philip McGuire; Allan H Young; Jae Il Shin; Christoph U Correll; Evangelos Evangelou
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

3.  PGC1α and VDAC1 expression in endometrial cancer.

Authors:  Ofra Castro Wersäll; Lina Löfstedt; Igor Govorov; Miriam Mints; Marike Gabrielson; Maria Shoshan
Journal:  Mol Clin Oncol       Date:  2020-12-30

Review 4.  The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis.

Authors:  Aneesha Kulkarni; Laura W Bowers
Journal:  Cell Mol Life Sci       Date:  2021-01-19       Impact factor: 9.261

Review 5.  Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis.

Authors:  E H Sutton; M Plyta; K Fragkos; S Di Caro
Journal:  Eur J Clin Nutr       Date:  2022-02-22       Impact factor: 4.016

6.  No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes.

Authors:  Elina Urpilainen; Anne Ahtikoski; Reetta Arima; Ulla Puistola; Peeter Karihtala
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

7.  Association Between Diet Quality and Risk of Ovarian and Endometrial Cancers: A Systematic Review of Epidemiological Studies.

Authors:  Yu-Hua Zhang; Zhuo Li; Ming-Zi Tan
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

8.  Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.

Authors:  Ana M Rodriguez; Efstathia Polychronopoulou; Enshuo Hsu; Rahul Shah; Kelly Lamiman; Yong-Fang Kuo
Journal:  Gynecol Oncol       Date:  2020-11-19       Impact factor: 5.482

Review 9.  Hearing impairment and diverse health outcomes : An umbrella review of meta-analyses of observational studies.

Authors:  Mike Trott; Lee Smith; Tao Xiao; Nicola Veronese; Ai Koyanagi; Louis Jacob; Guillermo F Lopez-Sanchez; Yvonne Barnett; Shahina Pardhan
Journal:  Wien Klin Wochenschr       Date:  2021-06-22       Impact factor: 1.704

10.  Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.

Authors:  Chris Stinton; Mary Jordan; Hannah Fraser; Peter Auguste; Rachel Court; Lena Al-Khudairy; Jason Madan; Dimitris Grammatopoulos; Sian Taylor-Phillips
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.